10,000 cancer records analyzed to supercharge future treatments
NCT ID NCT06018753
First seen Jun 25, 2026 · Last updated Jun 30, 2026 · Updated 3 times
Summary
This study collects and analyzes health records from 10,000 cancer patients across multiple sites. Researchers will use this real-world data to better understand patient populations, improve clinical trial design, and support drug development. No new treatments are tested—the goal is to learn from existing medical information.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help researchers design better cancer trials and understand how treatments work in everyday practice.
- What could go wrong
- This is an observational study, not a treatment trial. It won't directly help participants and may not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
77 people
The number who actually took part.
- Started
-
Dec 2023
- Finished
-
Jul 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The population of subjects targeted are: 1) those who have cancer, and 2) those for whom medical records are available.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Subjects must be diagnosed with cancer * Medical records available to meet cohort requirements Exclusion Criteria: \- None
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Avera Cancer Institute
Sioux Falls, South Dakota, 57105, United States
-
Cancer Specialists of Northern Florida
Jacksonville, Florida, 32256, United States
-
Community Health Network
Indianapolis, Indiana, 46256, United States
-
Hawaii Cancer Care
Honolulu, Hawaii, 96813, United States
-
Illinois Cancer Care
Peoria, Illinois, 61615, United States
-
Memorial Health Services
Fountain Valley, California, 98708, United States
-
Northwest Oncology and Hematology
Rolling Meadows, Illinois, 60008, United States
-
Sanford Fargo
Fargo, North Dakota, 58102, United States
-
Southcoast Centers for Cancer Care
Fairhaven, Massachusetts, 02719, United States
-
Taylor Cancer Research Center
Maumee, Ohio, 43537, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can colorectal surgery patients go home in two days?
- Can a personal navigator help young cancer patients through treatment?
- Can a smartwatch predict which cancer patients return to hospital?
- Two-Drug combo aims to stall advanced breast cancer
- Blood thinner flush could boost tumor biopsy success
- Could a frailty score predict which older cancer patients survive intensive care?